hiPSC bioprocessing
stem cell bioprocessing
low hiPSC expansion efficiency
hiPSC-cardiomyogenic differentiation
controlled hiPSC suspension culture
cost-effectiveness of scalable hiPSC expansion
cell-aggregates
Scalable ExpansIonand cardiac DifferentiatiON of hiPSC
novel bioreactor Platform
suspension culture Human
pluripotent stem cells
production of valuable human cell types
limited bioprocess reproducibility
enhanced reproducibility
generation automated bioreactor platform
pioneering bioreactor
non-impeller-dependent low
bioprocess standardisation
novel process
heterogeneity of cells
European excellence
cultured hiPSCs
biomedical sciences
POSEIDON project
automated systems
project outcomes
hydrodynamic conditions
working conditions
standardised mass production
Researcher’s professional development
fundamental leadership skills
excellent new expertise
significant track record
talented post-doc
indispensable
tremendous benefit
advanced engineering design methods
supervisor
pharmaceutical sectors
detrimental stresses
world leader
high costs
therapeutic use
Europe’s leading hubs
regenerative biomedicine
interdisciplinary collaboration
bioengineering
competitiveness
state
potential
scalability
group
proposed Fellowship
quality of life
tank bioreactors
ambitious purpose
major challenge
career perspectives
utility